What were the ten most clicked stories over the previous month? One topic has dominated the pharmacy news cycle like no other in recent weeks… and yes our top ten …

Tom Simpson, SHPA’s recently elected president, talks about his career in both pharmacy and E-health    When I attended Medicines Management 2022 in November last year, the newly elected President of …

The federal budget did contain some welcome initiatives to help the small business community While the attention of most in the pharmacy sector was on medicines policy when Federal Treasurer …

Federal Budget delivers expected pain for community pharmacy, with some minor gains, while general practice wins major concessions  Federal Treasurer Jim Chalmers has delivered what many in community pharmacy are …

The pharmacy world will be coming to Australia later in 2023, meanwhile a prominent health reformer will be speaking to the sector. Let’s look at the latest news in events …

The debate over the impact of 60-day dispensing rumbled on this week, while regulations tightened on paracetamol and e-cigarettes Pharmacy continued to express its opposition to the planned move to …

May 1948: Pharmacists were preparing for the launch of the Pharmaceutical Benefits Scheme on 1 June, despite ongoing opposition from doctors threatening its success Australia’s pharmacists were gearing up for …

Disruptor chain director speaks out on location/ownership rules, supermarkets moving into pharmacy…and the jelly bean wars The My Chemist director’s exclusive interview with AJP at the 2023 APP conference covered …

April 1923: Calls are growing for the government to close loopholes and restrict pharmacy ownership to pharmacists “It is a matter for regret that in the pharmacy laws of the …

The chess pieces have shifted noticeably for community pharmacy in recent days. AJP editor Chris Brooker reflects on what’s occurred and what may happen next   On Thursday 20th I closed …

We look at some of the recent changes to the medicines landscape, with new products as well as changes to indications New products Belzutifan (Welireg) is an inhibitor of hypoxia‑inducible …

Queensland’s urinary tract infection (UTI) pharmacy pilot is being hailed as a success by Dr Jean Spinks, a senior research fellow at the University of Queensland’s Centre for the Business …